Jafra Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-20,000
Closed -$1.59M 82
2018
Q2
$1.59M Sell
20,000
-10,000
-33% -$830K 0.55% 57
2018
Q1
$2.68M Buy
30,000
+6,341
+27% +$609K 0.83% 38
2017
Q4
$2.47M Sell
23,659
-38,498
-62% -$4.34M 0.69% 42
2017
Q3
$9.06M Buy
62,157
+180
+0.3% +$24.5K 3.37% 5
2017
Q2
$8.05M Buy
61,977
+21,877
+55% +$2.68M 2.98% 7
2017
Q1
$4.99M Buy
40,100
+29,919
+294% +$3.58M 2.01% 17
2016
Q4
$1.18M Buy
+10,181
New +$1.13M 0.99% 33

Other funds holding CELG

Jafra Capital Management's CELG Position: Q3 2018 in Review

Jafra Capital Management sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 20,000 shares — an estimated $1.59M sold.

Jafra Capital Management first reported a position in CELG in Q4 2016 and held it in 7 quarters. The position peaked at $9.06M in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Jafra Capital Management reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Jafra Capital Management sold 20,000 Celgene Corp shares in Q3 2018, an estimated $1.59M.
  • Jafra Capital Management first reported a position in Celgene Corp in Q4 2016 and held it in 7 quarters.
  • Jafra Capital Management's Celgene Corp position peaked at $9.06M in Q3 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Jafra Capital Management's 13F filing for Q3 2018.